---
figid: PMC7985550__fphar-12-632378-g003
figtitle: PI3K signaling pathway and related target drugs in vascular smooth muscle
  cells
organisms:
- Saccharomyces cerevisiae
- Glycine max
- Candida dubliniensis
- Aralia elata
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Staphylococcus aureus
- NA
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Glycine max
- Danio rerio
pmcid: PMC7985550
filename: fphar-12-632378-g003.jpg
figlink: pmc/articles/PMC7985550/figure/F3/
number: F3
caption: 'The PI3K signaling pathway and related target drugs in vascular smooth muscle
  cells. The PI3K signaling pathway has three main effects on vascular smooth muscle
  cells: 1. Proliferation and migration of smooth muscle cells. ① PDGF-BB activates
  PI3K/Akt/mTOR, promoting SMC proliferation and migration, while CTRP6 blocks this
  pathway ② Naringin inhibits TNF-α-induced PI3K/Akt/mTOR signaling, reduces MMP-9
  secretion and inhibits cell proliferation and migration. ③ Tanshinone I and dopamine
  D1-like receptors inhibit proliferation by inhibiting IGF-1/IGF-1R signaling. ④
  Apelin promotes migration through Apelin/APJ-mediated activation of PI3K/Akt/FOXO3a/MMP-2;
  furthermore, bone differentiation occurs through the inhibition of PI3K/Akt. ⑤ Ox-LDL
  promotes proliferation via PI3K/Akt/mTOR.⑥ Rosiglitazone inhibits INS/IR to activate
  PI3K/Akt/mTOR/P70S6K and promote proliferation. AGE/RAGE also promotes proliferation
  through PI3K/Akt 2. Osteogenic differentiation of smooth muscle cells⑦ VPO1 promotes
  ox-LDL-induced vascular calcification through the PI3K/AKT/Runx2 signaling pathway
  ⑧ miR-32 inhibits PTEN activity, promotes PI3K/Akt/RunX2 activation and exacerbates
  vascular calcification. ⑨ Lilaru peptide inhibits osteogenic differentiation by
  inhibiting PI3K/Akt/mTOR/S6K1 in combination with GLP-1R. ⑩Leptin promotes osteogenic
  differentiation via OB-Rb/PI3K/Akt/RANKL-BMP4. 3. Smooth muscle derived foam cells
  ⑪ miR-223 inhibits IGF-1/PI3K/Akt and Promote autophagy, reducing foam cell formation.'
papertitle: Role of PI3K in the Progression and Regression of Atherosclerosis.
reftext: Yunyun Zhao, et al. Front Pharmacol. 2021;12:632378.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9357296
figid_alias: PMC7985550__F3
figtype: Figure
redirect_from: /figures/PMC7985550__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7985550__fphar-12-632378-g003.html
  '@type': Dataset
  description: 'The PI3K signaling pathway and related target drugs in vascular smooth
    muscle cells. The PI3K signaling pathway has three main effects on vascular smooth
    muscle cells: 1. Proliferation and migration of smooth muscle cells. ① PDGF-BB
    activates PI3K/Akt/mTOR, promoting SMC proliferation and migration, while CTRP6
    blocks this pathway ② Naringin inhibits TNF-α-induced PI3K/Akt/mTOR signaling,
    reduces MMP-9 secretion and inhibits cell proliferation and migration. ③ Tanshinone
    I and dopamine D1-like receptors inhibit proliferation by inhibiting IGF-1/IGF-1R
    signaling. ④ Apelin promotes migration through Apelin/APJ-mediated activation
    of PI3K/Akt/FOXO3a/MMP-2; furthermore, bone differentiation occurs through the
    inhibition of PI3K/Akt. ⑤ Ox-LDL promotes proliferation via PI3K/Akt/mTOR.⑥ Rosiglitazone
    inhibits INS/IR to activate PI3K/Akt/mTOR/P70S6K and promote proliferation. AGE/RAGE
    also promotes proliferation through PI3K/Akt 2. Osteogenic differentiation of
    smooth muscle cells⑦ VPO1 promotes ox-LDL-induced vascular calcification through
    the PI3K/AKT/Runx2 signaling pathway ⑧ miR-32 inhibits PTEN activity, promotes
    PI3K/Akt/RunX2 activation and exacerbates vascular calcification. ⑨ Lilaru peptide
    inhibits osteogenic differentiation by inhibiting PI3K/Akt/mTOR/S6K1 in combination
    with GLP-1R. ⑩Leptin promotes osteogenic differentiation via OB-Rb/PI3K/Akt/RANKL-BMP4.
    3. Smooth muscle derived foam cells ⑪ miR-223 inhibits IGF-1/PI3K/Akt and Promote
    autophagy, reducing foam cell formation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igf1
  - C1qtnf6
  - Mmp9
  - Ager
  - Mok
  - Akt1
  - Mir223
  - Tnf
  - Runx2
  - Bmp4
  - Foxo3
  - Pten
  - Mir32
  - Aplnr
  - Mmp2
  - Glp1r
  - Pik3cg
  - PDGFB
  - IGF1
  - INS
  - IGF1R
  - C1QTNF6
  - MMP9
  - AGER
  - MOK
  - AKT1
  - AKT2
  - AKT3
  - MIR223
  - TNF
  - RORC
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - RUNX2
  - BMP4
  - FOXO3
  - PTEN
  - MIR32
  - APLNR
  - MMP2
  - GLP1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - F630028O10Rik
  - tor
  - Rorc
  - Jun
  - Pik3r1
  - AP1
  - SOYAP1
  - MP2
  - LOC547983
  - pdgfbb
  - igf1
  - ins
  - kita
  - ngfra
  - igf1rb
  - mmp9
  - mir223
  - tnfb
  - mtor
  - bmp4
  - ptenb
  - mmp2
  - Dopamine
  - tanshinone
  - Tosiglitazone
  - naringin
---
